Skip to main content

Table 2 TPM4 expression associated with clinicopathologic characteristics (logistic regression)

From: Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma

Characteristics

Total(N)

Odds Ratio (OR)

P value

WHO grade (G3&G4 vs. G2)

635

9.691 (6.603-14.472)

<0.001

1p/19q codeletion (noncodel vs. codel)

689

4.933 (3.334-7.444)

<0.001

Primary therapy outcome (PR&CR vs. PD&SD)

462

0.382 (0.253-0.570)

<0.001

IDH status (Mut vs. WT)

686

0.071 (0.047-0.106)

<0.001

Histological type (Astrocytoma&Oligoastrocytoma&Oligodendroglioma vs. Glioblastoma)

696

0.006 (0.001-0.020)

<0.001